Status:
ACTIVE_NOT_RECRUITING
Non-randomized Prospective Comparison Between SASI Bipartition and RYGB
Lead Sponsor:
Aleris Hospital
Conditions:
Obesity, Morbid
Metabolic Syndrome
Eligibility:
All Genders
18-70 years
Brief Summary
The main aim of this project is to assess the safety and efficiency of the SASI Bipartition.
Detailed Description
The Roux-en-Y Gastric Bypass (RYGB) is the procedure of choice in morbid obesity with metabolic disorders in most of the reference centers. Recent data describes the SASI Bipartition as being as effic...
Eligibility Criteria
Inclusion
- \- Morbid obesity with BMI ≥ 40 kg/m2 or BMI ≥ 35 kg/m2 associated with one or more co-morbidities (type 2 diabetes, arterial hypertension, sleep apnea, dyslipidemia, arthritis)
Exclusion
- Mental diseases
- Drug addiction
- Alcoholic
- Malignancy
- Pregnancy
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04469712
Start Date
August 1 2020
End Date
August 1 2027
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aleris Hospital
Oslo, Norway, 0264